New drug for IBD, ulcerative colitis wins FDA approval: ‘Amazing results’
A new drug for treating a type of inflammatory bowel disease (IBD) has been given the go-ahead by the Food and Drug Administration. On Friday, the FDA approved Pfizer’s etrasimod, branded as Velsipity, for treating adults with the chronic digestive disorder known as ulcerative colitis (UC). The oral, once-daily pill was granted approval after a … Read more